Ezetimibe & Simvastatin Tablets 10mg/10mg, 10mg/20mg Tablet

What is Ezetimibe & Simvastatin Tablets 10mg/10mg, 10mg/20mg Tablet?

Ezetimibe and Simvastatin Tablets combine two lipid-lowering medicines with complementary mechanisms of action. Available in 10 mg/10 mg and 10 mg/20 mg strengths, the formulation is used in the management of elevated cholesterol and certain mixed lipid disorders when combination therapy is clinically appropriate.

Uses / Indications

Ezetimibe and simvastatin tablets may be used in the management of lipid disorders, including:

• Primary hypercholesterolaemia
• Elevated low-density lipoprotein cholesterol (LDL-C)
• Mixed hyperlipidaemia in appropriate clinical settings
• Patients requiring additional LDL-C reduction despite dietary measures or statin therapy
• Patients for whom combination lipid-lowering treatment is clinically indicated

Treatment should generally be used alongside appropriate dietary and lifestyle measures.

Benefits

• Combines two complementary cholesterol-lowering mechanisms in a single tablet.
• Ezetimibe reduces intestinal absorption of cholesterol.
• Simvastatin reduces hepatic cholesterol synthesis.
• Supports reduction of LDL cholesterol as part of an appropriate lipid-management plan.
• Available in 10 mg/10 mg and 10 mg/20 mg strengths.

Side Effects

Common Side Effects

Possible side effects may include:

• Headache
• Abdominal discomfort
• Diarrhoea
• Nausea
• Constipation
• Muscle pain
• Fatigue
• Increased liver enzymes

Less Common or Serious Side Effects

Less common but clinically important reactions may include:

• Myopathy
• Rhabdomyolysis
• Significant muscle pain or weakness
• Liver-related abnormalities
• Hypersensitivity or allergic reactions
• Severe skin reactions
• Pancreatitis in rare circumstances

Patients experiencing unexplained severe muscle pain, weakness, or dark urine should seek prompt medical attention.

How Does It Work?

Ezetimibe

Ezetimibe reduces intestinal cholesterol absorption by inhibiting the NPC1L1 cholesterol transport pathway at the intestinal brush border. This reduces the delivery of cholesterol to the liver and contributes to lowering circulating LDL cholesterol.

Simvastatin

Simvastatin is an HMG-CoA reductase inhibitor, commonly known as a statin. It reduces hepatic cholesterol synthesis and promotes increased removal of LDL cholesterol from the bloodstream through increased hepatic LDL-receptor activity.

Combination Action

The two ingredients act through complementary pathways. Ezetimibe reduces cholesterol absorption from the intestine, while simvastatin reduces cholesterol synthesis in the liver. Their combined action can provide additional LDL-C reduction compared with either approach alone.

Dosage Guidelines

The appropriate strength and treatment duration depend on the patient’s lipid levels, cardiovascular risk, previous treatment, response, tolerability, and other clinical factors.

The exact dose and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

For tablets:

• Take exactly as prescribed.
• Swallow the tablet with sufficient water.
• Follow the prescribed treatment schedule.
• Do not crush, split or chew the tablet unless permitted by the approved product information.
• Continue recommended dietary and lifestyle measures.
• Do not alter the dose without professional advice.

When Not to Use

Ezetimibe and simvastatin should generally not be used in patients with:

• Known hypersensitivity to ezetimibe, simvastatin, or any component of the formulation
• Active liver disease or unexplained persistent elevations in serum transaminases where contraindicated
• Pregnancy
• Breastfeeding

Particular caution and professional assessment may be required in patients with a history of liver disease, renal impairment, thyroid disorders, or previous muscle-related adverse effects associated with statin treatment.

Drug / Product Interactions

Simvastatin is metabolised through the CYP3A4 pathway, and medicines that substantially inhibit this pathway can increase simvastatin exposure and the risk of muscle-related adverse effects.

Important interaction considerations may include:

• Strong CYP3A4 inhibitors
• Certain macrolide antibiotics
• Azole antifungal medicines
• HIV protease inhibitors and certain antiviral medicines
• Cyclosporine
• Gemfibrozil and certain other fibrates
• Warfarin and other vitamin K antagonists
• Grapefruit or grapefruit juice in significant amounts

Patients taking multiple medicines should provide their complete medication list to their healthcare professional before starting treatment.

Safety Advice

Overdose

If an overdose is suspected, seek immediate medical attention or contact an appropriate poison-control or emergency medical service.

Missed Dose

Take the missed dose when remembered unless it is nearly time for the next scheduled dose. If the next dose is due soon, skip the missed dose and continue with the regular schedule. Do not double the next dose unless specifically instructed by a healthcare professional.

Pregnancy

Ezetimibe and simvastatin should not generally be used during pregnancy. Cholesterol and other products of cholesterol biosynthesis have important roles in fetal development, and statin therapy is generally contraindicated during pregnancy.

Breastfeeding

Treatment with simvastatin is generally not recommended during breastfeeding. Use of this combination during breastfeeding should follow the approved product information and professional medical advice.

Children

Use in children and adolescents should follow the approved product information and age-specific clinical recommendations.

Elderly Patients

Older patients may require appropriate assessment of renal function, concurrent medicines, and risk factors for statin-associated muscle effects.

Renal Impairment

Renal function should be considered when selecting treatment, particularly because severe muscle injury can result in secondary renal complications. Patients with significant renal impairment may require closer clinical assessment.

Hepatic Impairment

Patients with active liver disease or unexplained persistent elevations in liver enzymes should be assessed before treatment. Appropriate liver-function monitoring may be required according to clinical circumstances.

General Instructions

• Take the medicine according to the prescribed schedule.
• Swallow the tablet with sufficient water.
• Follow the recommended dietary and lifestyle measures provided by the healthcare professional.
• Do not change the dose or strength without professional advice.
• Inform the healthcare professional about all medicines being taken.
• Avoid significant grapefruit or grapefruit juice intake unless specifically discussed with a healthcare professional.
• Report unexplained muscle pain, tenderness, or weakness.
• Keep the medicine in its original packaging where appropriate.
• Do not share prescription medicines with other people.

Special Dietary / Lifestyle Tips

A heart-healthy diet and appropriate physical activity may form part of the overall management of elevated cholesterol.

Reducing excessive intake of saturated fats and following dietary recommendations from a healthcare professional may support cholesterol management. Significant grapefruit or grapefruit juice consumption may need to be avoided because it can increase simvastatin exposure.

Comparison with Other Treatments

Ezetimibe and simvastatin combine inhibition of intestinal cholesterol absorption with reduction of hepatic cholesterol synthesis. Ezetimibe alone primarily reduces intestinal cholesterol absorption, while simvastatin alone primarily reduces hepatic cholesterol synthesis.

Other lipid-lowering medicines, including other statins, fibrates, bile acid sequestrants, PCSK9-targeting therapies, and other agents, have different mechanisms and clinical roles. Treatment selection depends on LDL-C levels, cardiovascular risk, tolerability, concurrent medicines, and the approved indication.

Precautions & Warnings

• Confirm any history of hypersensitivity to ezetimibe, simvastatin, or related medicines.
• Do not use during pregnancy.
• Breastfeeding considerations should follow the approved product information.
• Inform the healthcare professional about previous statin-associated muscle problems.
• Report unexplained muscle pain, tenderness, or weakness promptly.
• Seek immediate medical attention for severe muscle symptoms, particularly if accompanied by dark urine or marked weakness.
• Patients with liver disease require appropriate clinical assessment.
• Review concomitant medicines for interactions involving simvastatin metabolism.
• Avoid significant grapefruit or grapefruit juice consumption unless otherwise advised.
• Periodic lipid and laboratory assessments may be recommended according to clinical circumstances.

Can I Use It With Other Medicines?

Generally Compatible With

Ezetimibe and simvastatin can be used with many medicines when clinically appropriate. However, the complete medication profile should be reviewed because simvastatin has clinically important interaction potential.

Use With Caution / Avoid

Professional advice is particularly important when the product is used with:

• Strong CYP3A4 inhibitors
• Certain macrolide antibiotics
• Azole antifungal medicines
• Certain antiviral medicines
• Cyclosporine
• Gemfibrozil or certain other fibrates
• Warfarin or other vitamin K antagonists
• Significant amounts of grapefruit or grapefruit juice

Do not start, stop, or change other medicines without appropriate medical advice.

Storage

Store according to the storage conditions stated on the approved product label and package insert.

• Keep properly closed.
• Protect from excessive heat.
• Protect from moisture.
• Keep out of reach of children.
• Do not use after the expiry date.
• Keep in the original packaging where appropriate.

Frequently Asked Questions

1. What are Ezetimibe and Simvastatin Tablets used for?

Ezetimibe and simvastatin tablets are used as part of the management of elevated cholesterol and certain lipid disorders when combination lipid-lowering treatment is clinically appropriate.

2. What strengths are available for this formulation?

The formulation is available as 10 mg/10 mg and 10 mg/20 mg of ezetimibe and simvastatin, respectively.

3. How do Ezetimibe and Simvastatin work together?

Ezetimibe reduces cholesterol absorption from the intestine, while simvastatin reduces cholesterol synthesis in the liver. Their complementary actions help reduce circulating LDL cholesterol.

4. How should Ezetimibe and Simvastatin tablets be taken?

The tablet should be taken exactly as prescribed and swallowed with sufficient water. The selected strength and treatment duration should be determined according to the approved product information and clinical assessment.

5. Can Ezetimibe and Simvastatin be used during pregnancy?

This combination should not generally be used during pregnancy because statin therapy is contraindicated during pregnancy. Appropriate medical advice should be obtained if pregnancy occurs during treatment.

6. What should I do if I experience muscle pain?

Unexplained or persistent muscle pain, tenderness, or weakness should be reported to a healthcare professional. Severe muscle symptoms, particularly with dark urine or marked weakness, require prompt medical attention.

7. Can these tablets be taken with other medicines?

The combination can interact with medicines such as strong CYP3A4 inhibitors, certain antibiotics and antifungals, cyclosporine, fibrates, and some antiviral medicines. A healthcare professional should review the complete medication profile.

8. How should Ezetimibe and Simvastatin tablets be stored?

Store the product according to the conditions stated on the approved product label and package insert, and keep it out of reach of children.